Aquestive Therapeutics

0 followers

‌

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117.

Employees

201-500

Links


Org chart

Daniel Barber
CEO, President & Director
Collapse
Mark Schobel
Chief Innovation & Technology Officer
Carl Kraus
Chief Medical Officer
Lori J. Braender
SVP, General Counsel
Cassie Jung
SVP, Operations
Stephen Wargacki
SVP, Research & Development
Amy Santos
Vice President, Global Quality Assurance
Joseph Crusco
Director Business Development
Sherry Korczynski
Chief Commercial Officer (cco)
Olivia Passucci
Human Resources Director

Board & advisors

John Cochran
Director
Julie Krop
Director
Tim Morris
Director
David M. Fleischer
Scientific Advisor
David Golden
Scientific Advisor
Jay Lieberman
Scientific Advisor
David Bernstein
Scientific Advisor
Matthew Greenhawt
Scientific Advisor
Carlos Camargo
Scientific Advisor
Ruchi Gupta
Scientific Advisor
John Oppenheimer
Scientific Advisor